(b) If The chief commissioner establishes a plan less than this subchapter, the commissioner shall publish a report not later on than January 1 of each odd-numbered 12 months to the clinical performance of the use of tetrahydrocannabinols as well as their derivatives and any other professional medical results of your study software.(d) In analyzing